ONELZA Trademark

Trademark Overview


On Friday, March 31, 2006, a trademark application was filed for ONELZA with the United States Patent and Trademark Office. The USPTO has given the ONELZA trademark a serial number of 78851346. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 26, 2012. This trademark is owned by Biovail Laboratories International SRL. The ONELZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking excluding pharmaceutical preparations and substances delivered by transdermal plasters or transdermal patches; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments ...
onelza

General Information


Serial Number78851346
Word MarkONELZA
Filing DateFriday, March 31, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 26, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 27, 2007

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking excluding pharmaceutical preparations and substances delivered by transdermal plasters or transdermal patches; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, anti-inflammatories and pain relief medication excluding pain relief medication delivered by transdermal plasters or transdermal patches; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 6, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameValeant International (Barbados) SRL
Party Type21 - New Owner After Publication
Legal Entity Type99 - Other
AddressChrist Church BB17154
BB

Party NameBiovail Laboratories International SRL
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressChrist Church BB17154
BB

Party NameBiovail Laboratories International SRL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSt. Michael
BB

Trademark Events


Event DateEvent Description
Wednesday, January 21, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 22, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 22, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 26, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 26, 2012ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 1, 2012ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, May 4, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 3, 2012EXTENSION 5 GRANTED
Tuesday, April 24, 2012EXTENSION 5 FILED
Tuesday, April 24, 2012TEAS EXTENSION RECEIVED
Thursday, October 20, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 19, 2011EXTENSION 4 GRANTED
Monday, October 17, 2011EXTENSION 4 FILED
Monday, October 17, 2011TEAS EXTENSION RECEIVED
Tuesday, April 19, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 18, 2011EXTENSION 3 GRANTED
Wednesday, April 13, 2011EXTENSION 3 FILED
Wednesday, April 13, 2011TEAS EXTENSION RECEIVED
Wednesday, April 6, 2011ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 23, 2011ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, October 16, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 15, 2010EXTENSION 2 GRANTED
Wednesday, September 29, 2010EXTENSION 2 FILED
Friday, October 15, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 13, 2010ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, September 29, 2010TEAS EXTENSION RECEIVED
Friday, April 16, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 14, 2010EXTENSION 1 GRANTED
Wednesday, April 14, 2010EXTENSION 1 FILED
Wednesday, April 14, 2010TEAS EXTENSION RECEIVED
Tuesday, October 27, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 15, 2009TTAB RELEASE CASE TO TRADEMARKS
Tuesday, September 15, 2009OPPOSITION TERMINATED NO. 999999
Tuesday, September 15, 2009OPPOSITION DISMISSED NO. 999999
Friday, August 14, 2009PAPER RECEIVED
Wednesday, June 17, 2009ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, January 22, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 22, 2009TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 26, 2008OPPOSITION INSTITUTED NO. 999999
Friday, December 14, 2007EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, December 7, 2007CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Friday, November 30, 2007FAX RECEIVED
Tuesday, November 27, 2007PUBLISHED FOR OPPOSITION
Wednesday, November 7, 2007NOTICE OF PUBLICATION
Friday, October 19, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 19, 2007ASSIGNED TO LIE
Saturday, September 29, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 18, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 13, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 12, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 12, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 12, 2007TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, March 14, 2007FINAL REFUSAL E-MAILED
Wednesday, March 14, 2007FINAL REFUSAL WRITTEN
Tuesday, March 13, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 13, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 13, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 13, 2006NON-FINAL ACTION E-MAILED
Wednesday, September 13, 2006NON-FINAL ACTION WRITTEN
Wednesday, September 13, 2006ASSIGNED TO EXAMINER
Thursday, April 6, 2006NEW APPLICATION ENTERED IN TRAM